StockNews.com Begins Coverage on Brainstorm Cell Therapeutics (NASDAQ:BCLI)
Analysts at StockNews.com started coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Get Free Report) in a report released on Friday. The brokerage set a “hold” rating on the biotechnology company’s stock. Brainstorm Cell Therapeutics Trading Up 3.3 % Shares of BCLI stock opened at $1.86 on Friday. Brainstorm Cell Therapeutics has a 12-month […]
Analysts at StockNews.com started coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Get Free Report) in a report released on Friday. The brokerage set a “hold” rating on the biotechnology company’s stock. Brainstorm Cell Therapeutics Trading Up 3.3 % Shares of BCLI stock opened at $1.86 on Friday. Brainstorm Cell Therapeutics has a 12-month […]
